Anglotaz 1.125gm Injection
Marketer
Brook Parker
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Anglotaz 1.125gm Injection
Benzamycin 1.125g injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administration should always be performed by a medical professional; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on the infection's severity, requiring adherence to the prescribed regimen. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rash), and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, disclose any antibiotic allergies, kidney, or liver conditions to your doctor; adjustments to dosage or alternative medications may be necessary. While generally safe under medical supervision, its use during pregnancy and breastfeeding should be discussed with your physician.
Primary Ingredients of Anglotaz 1.125gm Injection
No text provided to rephrase.
Uses of Anglotaz 1.125gm Injection
Infections caused by bacteria
Major Benefits of Anglotaz 1.125gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Anglotaz 1.125gm Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Anglotaz 1.125gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Anglotaz 1.125gm Injection works:
Anglotaz 1.125gm Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counters bacterial resistance, thereby boosting Piperacillin's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Anglotaz 1.125gm Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Anglotaz, 1.125gm, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Anglotaz 1.125gm Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Anglotaz 1.125gm Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Anglotaz 1.125gm Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Anglotaz 1.125gm Injection in individuals with hepatic impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Anglotaz 1.125gm Injection :
Omit a scheduled Anglotaz 1.125gm Injection? Seek medical advice immediately.
Facts to Know About Anglotaz 1.125gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently